The primary endpoint has now changed from assisting people who were not going to die from their illness, to assisting people who were otherwise going to die!!! And the treatment working 60% of the time in saving LIFE!!!
MSB have just changed the goal of the primary endpoint with their data, and now its HUGE, saves life rather than assisting non terminal endpoints. I can't get over how good this news is. First of all (REVASCOR®) was a bit part to the MSB story, now this is now a company maker. With more products to follow in the readouts of Phase 3 trials, this company is one of those unicorns that you watch on charts and wonder what it would have been like on that ride. This is that one
Ann: Mesoblast Phase 3 Chronic Heart Failure Results, page-124
-
- There are more pages in this discussion • 899 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.02 |
Change
0.013(1.24%) |
Mkt cap ! $1.153B | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.02 | 94.0¢ | $8.576M | 8.790M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 49171 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.02 | 131148 | 15 |
View Market Depth
| Last trade - 14.10pm 31/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |